North America

Home

Strategic Locations

IDT Biologika is a global biologics CDMO offering development and manufacture of Vaccines and Viral Vectors, and aseptic liquid filling and lyophilization of a range of biologics. Our U.S. facility in Rockville, Maryland is close to Washington D.C., the US National Institutes of Health, and is located in a hub for biologics manufacturing.

Legacy in Biologics Contract Manufacturing

The Rockville site has a long history of biologics contract manufacturing and state-of-the-art technologies used to develop and manufacture clinical trial materials for vaccines and cell & gene therapeutics. We provide clinical phase I–II manufacturing at the Rockville site, which is convenient for customers located in North America.

Close collaboration between Rockville and Germany allows access to IDT global network capabilities for IDT Rockville customers.

In 2022-23
Over 15 different customer programs for process and analytical development, cell banking, virus seed banking, clinical (Phase I/ II) drug substance, fill/finish, release testing and stability studies.

IDT Rockville Site Overview

Process & Analytical Development

We have a Process Development Team in Rockville comprising scientists and engineers highly experienced in complex upstream and downstream processes and formulation. We help our customers overcome challenges with their products by defining the appropriate technologies and employing our experience to refine a process that works and can be scaled.

Our Quality Control and Analytical Development Teams support a wide array of analytical technologies needed to develop novel assays for the characterization, release, and stability testing of early-phase vaccines, gene therapy vectors, and protein therapeutics.

Upstream Process